Antidepressive treatments for Parkinson's disease: A systematic review and meta-analysis

Medicine and Dentistry

• Therapeutic Procedure 100%
• Parkinson's Disease 100%
• Patient 100%
• Meta-Analysis 100%
• Randomized Controlled Trial 75%
• Depression 62%
• Placebo 25%
• Gender 25%
• Antidepressant 25%
• Repetitive Transcranial Magnetic Stimulation 25%
• Quality of Life 12%
• Drug 12%
• Chemotherapeutic Agent 12%
• Assessment 12%
• Age 12%
• Comorbidity 12%
• Effect Size 12%
• Antidepressant Medication 12%
• Selective Serotonin Reuptake Inhibitor 12%

Nursing and Health Professions

• Parkinson Disease 100%
• Meta Analysis 100%
• Systematic Review 100%
• Depression 62%
• Behavioral Intervention 37%
• Antidepressant 37%
• Standard 12%
• Drug 12%
• Data Base 12%
• Quality of Life 12%
• Drug Therapy 12%
• Confidence Interval 12%
• Placebo 12%
• Comorbidity 12%
• CINAHL 12%
• Effect Size 12%
• Medline 12%
• Data Extraction 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Parkinson Disease 100%
• Depression 62%
• Antidepressant 37%
• Drug 12%
• Comorbidity 12%
• Selective Serotonin Reuptake Inhibitor 12%